Table I.

Patient characteristics

Patient
 IDAgeSexDiagnosisStagePrevious therapyDisease status
 at entryDisease
 at study entryBest response
 on studyDuration
 on studyCurrent
 status
yrmo
K-162MmyelomaIIIchemotherapy,
 stem cell transplantprogressiveurine M spike
 3.3 g/durine M spike
 3.0 g/d9alive
K-241MmyelomaIIIchemotherapy,
 stem cell transplantstableserum M spike
 1.0 g/dlserum M spike
 0.4 g/dl10alive
K-357Manal cancer
 (squamous cancer)IVradiation,
 chemotherapy, surgeryprogressivemetastases to liver,
 peritoneumnone4deceased
K-470Mrenal cell cancerIVsurgery, IFN, TK inhibitorprogressivemetastases to lung,
 adrenalstable metastatic
 disease8+alive
K-563MmyelomaIIIradiation, chemotherapy,
 stem cell transplantstableurine M spike
 116 mg/durine M spike
 79 mg/d10+alive